NCT01471093View on ClinicalTrials.gov

Safety Study of OPC-12759 Ophthalmic Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

February 29, 2012

Conditions
Dry Eye Syndromes
Interventions
DRUG

OPC-12759 Ophthalmic solution

2％ OPC-12759 Ophthalmic solution

DRUG

OPC-12759 Ophthalmic suspension

2％ OPC-12759 Ophthalmic suspension

Trial Locations (1)

Unknown

Kansai region, Osaka

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY